temozolomide has been researched along with Rhabdomyosarcoma 2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kinoshita, M | 1 |
Yamada, A | 1 |
Sawa, D | 1 |
Kamimura, S | 1 |
Miyachi, M | 1 |
Moritake, H | 1 |
Paulino, AC | 1 |
Pappo, A | 1 |
Mixon, BA | 1 |
Eckrich, MJ | 1 |
Lowas, S | 1 |
Engel, ME | 1 |
3 other studies available for temozolomide and Rhabdomyosarcoma 2
Article | Year |
---|---|
Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child, Preschool; C | 2018 |
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Mod | 2009 |
Vincristine, irinotecan, and temozolomide for treatment of relapsed alveolar rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Child; Child, Preschool; Dacarbazine; | 2013 |